Results 211 to 220 of about 8,521 (239)

Effect of phosphodiesterase inhibitors on platelet function. [PDF]

open access: yesBiochem Biophys Rep
Hochuli R   +7 more
europepmc   +1 more source

A nonactivating <i>ITGB3</i> mutation in the β3 cytoplasmic region causes macrothrombocytopenia with an impaired αIIbβ3/RhoA pathway. [PDF]

open access: yesBlood Vessel Thromb Hemost
Nakata K   +9 more
europepmc   +1 more source

Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2, and PRN473 reduces venous thrombosis formation in mice. [PDF]

open access: yesBlood Adv
Smith CW   +25 more
europepmc   +1 more source

Recurrent Cerebral Hemorrhaging with Platelet Dysfunction Accompanied by Anti-glycoprotein VI Autoantibodies in a Patient with TAFRO Syndrome. [PDF]

open access: yesIntern Med
Yamamoto A   +15 more
europepmc   +1 more source

A minimum valency of four is required for robust activation of platelets in flow cytometry by multivalent nanobodies to GPVI, CLEC-2 and PEAR1

open access: gold
Rachel E. Lamerton   +5 more
openalex   +1 more source

A GPVI signalling defect in newly formed platelets generated in stress thrombopoiesis

open access: hybrid
Stephanie R. Hyslop   +11 more
openalex   +1 more source

Suppressed ORAI1-STIM1-dependent Ca<sup>2+</sup> entry by protein kinase C isoforms regulating platelet procoagulant activity. [PDF]

open access: yesJ Biol Chem
Zou J   +12 more
europepmc   +1 more source

Soluble glycoprotein VI predicts abdominal aortic aneurysm growth rate and is a novel therapeutic target.

open access: yesBlood
Benson TW   +30 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy